Health Catalyst (HCAT) Current Deferred Revenue (2018 - 2026)
Health Catalyst filings provide 9 years of Current Deferred Revenue readings, the most recent being $69.7 million for Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 3.01% to $69.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $69.7 million, a 3.01% decrease, with the full-year FY2025 number at $56.5 million, up 5.61% from a year prior.
- Current Deferred Revenue hit $69.7 million in Q1 2026 for Health Catalyst, up from $56.5 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $71.9 million in Q1 2025 to a low of $52.2 million in Q3 2024.
- Median Current Deferred Revenue over the past 5 years was $59.2 million (2025), compared with a mean of $60.0 million.
- Biggest five-year swings in Current Deferred Revenue: dropped 5.82% in 2023 and later grew 19.42% in 2025.
- Health Catalyst's Current Deferred Revenue stood at $55.1 million in 2022, then increased by 1.27% to $55.8 million in 2023, then fell by 4.12% to $53.5 million in 2024, then grew by 5.61% to $56.5 million in 2025, then increased by 23.43% to $69.7 million in 2026.
- The last three reported values for Current Deferred Revenue were $69.7 million (Q1 2026), $56.5 million (Q4 2025), and $59.2 million (Q3 2025) per Business Quant data.